Nafamostat mesylate, an apparent soi-disant panacea of sorts, is widely used to
anticoagulate patients undergoing hemodialysis or cardiopulmonary bypass, mitigate the …

Nafamostat mesylate, an apparent soi-disant panacea of sorts, is widely used to
anticoagulate patients undergoing hemodialysis or cardiopulmonary bypass, mitigate the …

Nafamostat mesilate (NM), a serine protease inhibitor, has a broad range of clinical
applications that include use as an anticoagulant during hemodialysis in cerebral …

Evidence suggests that thrombin, a blood coagulation serine protease, mediates neuronal
injury in experimental cerebral ischemia. Here, we test the hypothesis that nafamostat …

Background Nafamostat mesylate (nafamostat, NM) is an FDA-approved serine protease
inhibitor that exerts anti-neuroinflammation and neuroprotective effects following rat spinal …

Inflammation plays an important role in stroke pathology, making it a promising target for
stroke intervention. Nafamostat mesilate (NM), a wide-spectrum serine protease inhibitor, is …

This study aimed to evaluate the effects of nafamostat, a serin protease inhibitor, in the
management of subarachnoid hemorrhage (SAH). SAH was induced by endovascular …

dl-3-n-Butylphthalide (NBP) has shown cytoprotective effects in animal models of stroke and
has passed clinical trials as a therapeutic drug for stroke in China. Hence, as a potential …

Purpose: The present study was to observe the therapeutic efficiency of Clematichinenoside
(AR) on cerebral ischemic injury in rats, especially on neurological and motor function …

Objective To investigate the protective effects of sodium tanshinone B (STB) on brain
damage following focal ischemia-reperfusion (I/R) injury through interfering with N-methyl-D …